Press Releases
Mylan NV launches generic version of Celgenes Vidaza injection
Mylan N.V. announced the U.S. launch of Azacitidine for Injection, 100 mg/vial, which is a generic version of Celgene's Vidaza® Injection, 100 mg/vial. Mylan received...
Press Releases
Peregrine Pharmaceuticals Updates Highlighting Latest Developments for Contract Manufacturing...
Contract Manufacturing Revenue Hits All-Time High of $44 Million for Fiscal Year Ended April 2016; Fiscal Year 2017 Contract Manufacturing Revenue Projected Between $50-55 Million;...
Press Releases
EU approves Novartis drug Afinitor to treat certain types...
Novartis announced that the EU has approved Afinitor®(everolimus) tablets for the treatment of unresectable or metastatic, well-differentiated (Grade 1 or Grade 2) nonfunctional neuroendocrine tumors...
Press Releases
Bayer collaborates with U.S. National Surgical Adjuvant Breast and...
Study will include patients with Stage IIIB and IIIC colon cancer who have undergone complete surgical resection of primary tumor and received standard adjuvant chemotherapy...
Press Releases
Allergan receives US FDA marketing approval for Juvederm Volbella...
Allergan plc a leading global pharmaceutical company announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM...
Press Releases
Alexion Pharma (ALXN) Granted Ophand Drug Status in Europe...
Alexion Pharmaceuticals Inc announced that the EC as granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting C5 antibody being evaluated in patients...
Press Releases
EC Approves the AbbVies IMBRUVICA for First-Line Treatment of...
AbbVie a global biopharmaceutical company announced that the EC approved IMBRUVICA® (ibrutinib) as a first-line treatment option for adult patients with chronic lymphocytic leukemia (CLL),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.